Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 Months-Reference-Cited by-同舟云学术

Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 Months

Published:1991-04 Issue:4_pt_1 Volume:143 Page:700-706
ISSN:0003-0805
Container-title:American Review of Respiratory Disease
language:en
Short-container-title:Am Rev Respir Dis

Author:

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference9 articles.

1. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis

2. Five-Year Follow-Up of a Clinical Trial of Three 6-Month Regimens of Chemotherapy Given Intermittently in the Continuation Phase in the Treatment of Pulmonary Tuberculosis

3. A sensitive urine-test method for monitoring the ingestion of isoniazid.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data;BMJ Open Respiratory Research;2023-11

2. Transmissibility of tuberculosis among students and non-students: an occupational-specific mathematical modelling;Infectious Diseases of Poverty;2022-12-02

3. The Medical Management of Spinal Tuberculosis;Tuberculosis of the Spine;2022

4. An Overview of New Strategies Based on Functional Nanoscale Materials to the Treatment of Tuberculosis;Functional Properties of Advanced Engineering Materials and Biomolecules;2021

5. Tuberculosis treatment in children: The changing landscape;Paediatric Respiratory Reviews;2020-11